ACA
JNJ icon

Ascension Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Ascension Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
4,577
+96
+2% +$22.4K 0.33% 30
2026
Q1 		$1.1M Buy
+4,481
New +$1.04M 0.34% 27

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ascension Capital Advisors's JNJ Position: Q2 2026 in Review

Ascension Capital Advisors increased its Johnson & Johnson (JNJ) stake by 2.1% in Q2 2026, buying an estimated $22.4K and bringing the position to 4,577 shares worth $1.16M. The position accounts for 0.33% of the portfolio, ranked #30.

Ascension Capital Advisors first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ascension Capital Advisors held 4,577 shares of Johnson & Johnson worth $1.16M as of Q2 2026.
  • Ascension Capital Advisors bought 96 Johnson & Johnson shares in Q2 2026, an estimated $22.4K.
  • Johnson & Johnson made up 0.33% of Ascension Capital Advisors's portfolio in Q2 2026, its #30 holding.
  • Ascension Capital Advisors first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ascension Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.